Integration der Hemmung des MAPK-Signalwegs in die Standardtherapie für pädiatrisches niedriggradiges Gliom

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1BRAF/MEK inhibitors use for pediatric gliomas; real world experience from a resource-limited country2024 · 12 citations
2. 2Optic gliomas in children with neurofibromatosis type 11989 · 307 citations
3. 3Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma2015 · 339 citations
4. 4The 2021 WHO Classification of Tumors of the Central Nervous System: a summary2021 · 11,963 citations
5. 5LGG-53. RESULTS FROM THE PHASE 1 AND PHASE 1 EXPANSION COHORTS OF SJ901: A PHASE 1/2 TRIAL OF SINGLE-AGENT MIRDAMETINIB (PD-0325901) IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOW-GRADE GLIOMA2024 · 6 citations